AbCellera Biologics Inc. (ABCL): Price and Financial Metrics

AbCellera Biologics Inc. (ABCL): $3.97

0.04 (-1.00%)

POWR Rating

Component Grades








Add ABCL to Watchlist
Sign Up

Industry: Biotech




#343 of 359

in industry

ABCL Price/Volume Stats

Current price $3.97 52-week high $8.05
Prev. close $4.01 52-week low $3.79
Day low $3.96 Volume 1,595,100
Day high $4.31 Avg. volume 1,364,199
50-day MA $4.67 Dividend yield N/A
200-day MA $5.16 Market Cap 1.16B

ABCL Stock Price Chart Interactive Chart >

AbCellera Biologics Inc. (ABCL) Company Bio

AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics. It was founded in 2012 and headquartered in Vancouver, British Columbia.

ABCL Latest News Stream

Event/Time News Detail
Loading, please wait...

ABCL Latest Social Stream

Loading social stream, please wait...

View Full ABCL Social Stream

Latest ABCL News From Around the Web

Below are the latest news stories about ABCELLERA BIOLOGICS INC that investors may wish to consider to help them evaluate ABCL as an investment opportunity.

AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024

VANCOUVER, British Columbia, December 20, 2023--AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 2:15 p.m. Pacific Time (5:15 p.m. Eastern Time).

Yahoo | December 20, 2023

AI Meets Biotech: 3 Top Stocks Transforming Medical Science

The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology.

John Blankenhorn on InvestorPlace | December 16, 2023

16 Best Penny Stocks To Buy For 2024

In this article, we will take a detailed look at the 16 Best Penny Stocks To Buy For 2024. For a quick overview of such stocks, read our article 5 Best Penny Stocks To Buy For 2024. The stock market’s optimism wave recently saw a break after latest data showed that the US labor market remains resilient despite […]

Yahoo | December 11, 2023

Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November

The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions. | December 6, 2023

AbCellera Biologics Insiders Added US$2.47m Of Stock To Their Holdings

Over the last year, a good number of insiders have significantly increased their holdings in AbCellera Biologics Inc...

Yahoo | November 24, 2023

Read More 'ABCL' Stories Here

ABCL Price Returns

1-mo -13.32%
3-mo -25.38%
6-mo 1.53%
1-year -41.01%
3-year -86.46%
5-year N/A
YTD -30.47%
2023 -43.63%
2022 -29.16%
2021 -64.46%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!